SCOPUS 정보 검색 플랫폼

Volumn 30, Issue 5, 2002, Pages 553-563

The metabolism and excretion of galantamine in rats, dogs, and humans

(12) Mannens, G S J a Snel, C A W a Hendrickx, J a Verhaeghe, T a Le Jeune, L a Bode, W a Van Beijsterveldt, L a Lavrijsen, K a Leempoels, J a Van Osselaer, N a Van Peer, A a Meuldermans, W a

a JANSSEN RESEARCH AND DEVELOPMENT (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DRUG METABOLITE; GALANTAMINE; GLUCURONIDE; O NORGALANTAMINE; OXIDE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DOG; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG FECES LEVEL; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG OXIDATION; DRUG STRUCTURE; DRUG URINE LEVEL; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; ISOMERISM; MALE; NONHUMAN; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLINESTERASE INHIBITORS; DOGS; FECES; FEMALE; GALANTAMINE; HUMANS; MALE; RATS; RATS, WISTAR;

ANIMALIA; CANIS FAMILIARIS;

EID: 18344368417 PISSN: 00909556 EISSN: None Source Type: Journal
DOI: 10.1124/dmd.30.5.553 Document Type: Article

Times cited : (90)

References (11)

1
- 0033408375
- The O-demethylation of the antidementia drug galanthamine is catalyzed by cytochrome P450 2D6
- (1999) Pharmacogenetics , vol.9 , pp. 661-668
- Bachus, R.¹ Bickel, U.² Thomsen, T.³ Roots, I.⁴ Kewitz, H.⁵

2
- 0025765379
- Galanthamine: Pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice
- (1991) Neuropharmacology , vol.30 , pp. 447-454
- Bickel, U.¹ Thomsen, T.² Fischer, J.P.³ Weber, W.⁴ Kewitz, H.⁵

3
- 0025953079
- Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
- (1991) Clin Pharmacol Ther , vol.50 , pp. 420-428
- Bickel, U.¹ Thomsen, T.² Weber, W.³ Fischer, J.P.⁴ Bachus, R.⁵ Nitz, M.⁶ Kewitz, H.⁷

4
- 0022453239
- Pharmacokinetics of galanthamine hydrobromide (Nivalin) following single intravenous and oral administration in rats
- (1986) Pharmacology , vol.32 , pp. 301-306
- Mihailova, D.¹ Yamboliev, I.²

5
- 0022408070
- Modelling of pharmacokinetic and pharmacodynamic behavior of Nivalin in anaesthetized cats
- (1985) Methods Find Exp Clin Pharmacol , vol.7 , pp. 595-601
- Mihailova, D.¹ Yamboliev, I.² Dishovski, C.H.³

6
- 0024372802
- Pharmacokinetics of galanthamine hydrobromide after single subcutaneous and oral dosage in humans
- (1989) Pharmacology , vol.39 , pp. 50-58
- Mihailova, D.¹ Yamboliev, I.² Shivkova, Z.³ Tencheva, J.⁴ Jovovich, V.⁵

7
- 0034720816
- A 6-month randomized, placebo-controlled trial with a 6-month extension
- (2000) Neurology , vol.54 , pp. 2261-2268
- Raskind, M.A.¹ Peskind, E.R.² Wessel, T.³ Yuan, W.⁴

8
- 0034720864
- A 5-month, randomized, placebo-controlled trial of galantamine in AD
- (2000) Neurology , vol.54 , pp. 2269-2276
- Tariot, P.N.¹ Solomon, P.R.² Morris, J.C.³ Kershaw, P.⁴ Lilienfield, S.⁵ Ding, C.⁶

9
- 0023029529
- Pharmacokinetics of galanthamine (a long acting anticholinesterase drug) in anaesthetized patients
- (1986) Br J Anaesth , vol.38 , pp. 1303-1307
- Westra, P.¹ Van Thiel, M.J.S.² Vermeer, G.A.³ Soeterbrodk, A.M.⁴ Scaf, A.H.J.⁵ Claessens, H.A.⁶

10
- 0000406791
- Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial
- (2000) Br Med J , vol.321 , pp. 1-7
- Wilcock, G.K.¹ Lilienfield, S.² Gaens, E.³

11
- 0034810025
- Galantamine: A randomized, double-blind, dose comparison in patients with Alzheimer's disease
- (2001) Int J Geriatr Psychiatry , vol.16 , pp. 852-857
- Wilkinson, D.¹ Murray, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.